Mr Toshiki Sekiya
Honorary Senior Fellow
Department of Microbiology and Immunology
9 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
ARNAX is an ideal adjuvant for COVID-19 vaccines to enhance antigen-specific CD4 and CD8 T-cell responses and neutralizing antibody induction
DOI: 10.1128/jvi.02290-242024
Journal article
Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine
DOI: 10.1038/s41598-024-54421-12022
Journal article
Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques
DOI: 10.1371/journal.ppat.10108912021
Journal article
Immune profiling of influenza-specific B- and T-cell responses in macaques using flow cytometry-based assays
DOI: 10.1111/imcb.123832019
Journal article
Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza
DOI: 10.1016/j.vaccine.2019.02.0572017
Journal article
PEGylation of a TLR2-agonist-based vaccine delivery system improves antigen trafficking and the magnitude of ensuing antibody and CD8 T cell responses
DOI: 10.1016/j.biomaterials.2017.05.0182015
Journal article
Inactivated influenza vaccine that provides rapid, innate-immune- system-mediated protection and subsequent long-term adaptive immunity
DOI: 10.1128/mBio.01024-15
RECENT SCHOLARLY WORKS
2015
Journal article
A single dose biodegradable vaccine depot that induces persistently high levels of antibody over a year
DOI: 10.1016/j.biomaterials.2015.02.0662012
Journal article
Hepatitis C VLPs Delivered to Dendritic Cells by a TLR2 Targeting Lipopeptide Results in Enhanced Antibody and Cell-Mediated Responses
DOI: 10.1371/journal.pone.0047492